Association of serological markers with endoscopic mucosal healing and disease activity in patients with inflammatory bowel disease: a retrospective study - Scorecard - MDSpire
Advertisement
Correlation of Serological Biomarkers with Endoscopic Mucosal Recovery and Disease Activity in Inflammatory Bowel Disease Patients: A Retrospective Analysis
Clinical Scorecard: Correlation of Serological Biomarkers with Endoscopic Mucosal Recovery and Disease Activity in Inflammatory Bowel Disease Patients: A Retrospective Analysis
At a Glance
Category
Detail
Condition
Inflammatory Bowel Disease (IBD)
Key Mechanisms
Serological markers associated with mucosal healing and inflammation.
Target Population
Patients with ulcerative colitis (UC) and Crohn’s disease (CD).
Care Setting
Retrospective analysis in a clinical hospital setting.
Key Highlights
CRP, TNF-α, ESR, and PLT levels are elevated in active IBD patients.
ALB levels are reduced in active IBD patients compared to controls.
Combined serological tests show higher predictive efficacy for mucosal healing.
Serum levels of biomarkers correlate with disease inflammation.
Endoscopic mucosal healing is linked to better long-term prognosis.
Guideline-Based Recommendations
Diagnosis
Use of serological markers for assessing disease activity in IBD.
Management
Endoscopic evaluation is crucial for monitoring treatment effects.
Monitoring & Follow-up
Routine measurement of CRP, TNF-α, ESR, PLT, and ALB for disease activity.
Risks
Active IBD is associated with increased risk of mucosal injury and recurrence.
